China Investigational New Drug CDMO Market (2025-2031) | Companies, Share, Trends, Competitive Landscape, Value, Industry, Size & Revenue, Analysis, Segmentation, Growth, Forecast, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Investigational New Drug CDMO Market Revenues & Volume, 2021 & 2031F

3.3 China Investigational New Drug CDMO Market - Industry Life Cycle

3.4 China Investigational New Drug CDMO Market - Porter's Five Forces

3.5 China Investigational New Drug CDMO Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 China Investigational New Drug CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F

3.7 China Investigational New Drug CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for outsourcing services in the pharmaceutical industry

4.2.2 Growth in RD activities in China

4.2.3 Favorable government policies supporting the development of the pharmaceutical sector

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval

4.3.2 Intense competition among CDMO service providers

4.3.3 Challenges in maintaining quality standards and compliance

6.1 China Investigational New Drug CDMO Market, By Product

6.1.1 Overview and Analysis

6.1.2 China Investigational New Drug CDMO Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 China Investigational New Drug CDMO Market Revenues & Volume, By Small Molecule, 2021- 2031F

6.1.4 China Investigational New Drug CDMO Market Revenues & Volume, By Large Molecule, 2021- 2031F

6.2 China Investigational New Drug CDMO Market, By Service

6.2.1 Overview and Analysis

6.2.2 China Investigational New Drug CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F

6.2.3 China Investigational New Drug CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F

6.3 China Investigational New Drug CDMO Market, By End-user

6.3.1 Overview and Analysis

6.3.2 China Investigational New Drug CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F

6.3.3 China Investigational New Drug CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F

6.3.4 China Investigational New Drug CDMO Market Revenues & Volume, By Others, 2021- 2031F

7.1 China Investigational New Drug CDMO Market Export to Major Countries

7.2 China Investigational New Drug CDMO Market Imports from Major Countries

8.1 Percentage of successful IND submissions processed by China investigational new drug CDMOs

8.2 Number of new partnerships and collaborations with pharmaceutical companies

8.3 Average turnaround time for IND manufacturing and development by China investigational new drug CDMOs

9.1 China Investigational New Drug CDMO Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 China Investigational New Drug CDMO Market Opportunity Assessment, By Service, 2021 & 2031F

9.3 China Investigational New Drug CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 China Investigational New Drug CDMO Market Revenue Share, By Companies, 2024

10.2 China Investigational New Drug CDMO Market Competitive Benchmarking, By Operating and Technical Parameters